WO2014056722A3 - Formulation aqueuse stérile injectable à base d'acide hyaluronique réticulé et d'hydroxyapatite pour usage esthétique - Google Patents
Formulation aqueuse stérile injectable à base d'acide hyaluronique réticulé et d'hydroxyapatite pour usage esthétique Download PDFInfo
- Publication number
- WO2014056722A3 WO2014056722A3 PCT/EP2013/069874 EP2013069874W WO2014056722A3 WO 2014056722 A3 WO2014056722 A3 WO 2014056722A3 EP 2013069874 W EP2013069874 W EP 2013069874W WO 2014056722 A3 WO2014056722 A3 WO 2014056722A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydroxyapatite
- hyaluronic acid
- sterile aqueous
- aqueous formulation
- crosslinked hyaluronic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Abstract
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES13766322.5T ES2668689T3 (es) | 2012-10-08 | 2013-09-24 | Formulación acuosa estéril inyectable a base de ácido hialurónico reticulado e hidroxiapatita para uso estético |
AU2013329751A AU2013329751B2 (en) | 2012-10-08 | 2013-09-24 | Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
SG11201502743PA SG11201502743PA (en) | 2012-10-08 | 2013-09-24 | Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
KR1020157009968A KR101773989B1 (ko) | 2012-10-08 | 2013-09-24 | 가교된 히알루론산 및 수산화 인회석 기재의 에스테틱 용도로 주입가능한 멸균 수계 제형 |
MX2015004307A MX360833B (es) | 2012-10-08 | 2013-09-24 | Formulacion acuosa esteril inyectable basada en acido hialuronico reticulado e hidroxiapatita para uso para estético. |
RU2015115974A RU2648450C2 (ru) | 2012-10-08 | 2013-09-24 | Приемлемая для инъекций стерильная водная композиция на основе сшитой гиалуроновой кислоты и гидроксиапатита для применения в пластической хирургии |
PL13766322T PL2903589T3 (pl) | 2012-10-08 | 2013-09-24 | Wodna sterylna formulacja do wstrzykiwania na bazie usieciowanego kwasu hialuronowego i hydroksyapatytu do stosowania estetycznego |
US14/433,927 US20150257989A1 (en) | 2012-10-08 | 2013-09-24 | Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
BR112015007772A BR112015007772B1 (pt) | 2012-10-08 | 2013-09-24 | formulação aquosa estéril injetável contendo ácido hialurônico reticulado e de hidroxiapatita para uso estético |
CN201380052596.3A CN104703582B (zh) | 2012-10-08 | 2013-09-24 | 用于化妆品的包含交联透明质酸和羟基磷灰石的注射用无菌水性制剂 |
EP13766322.5A EP2903589B1 (fr) | 2012-10-08 | 2013-09-24 | Formulation aqueuse stérile injectable à base d'acide hyaluronique réticulé et d'hydroxyapatite pour usage esthétique |
LTEP13766322.5T LT2903589T (lt) | 2012-10-08 | 2013-09-24 | Injekcinė sterili vandeninė kompozicija, pagaminta iš tinklinės struktūros hialurono rūgšties ir hidroksiapatito, estetiniam naudojimui |
JP2015536048A JP6342906B2 (ja) | 2012-10-08 | 2013-09-24 | 架橋されたヒアルロン酸及びヒドロキシアパタイトに基づく、美容用途のための注射可能な無菌水性製剤 |
CA2887316A CA2887316C (fr) | 2012-10-08 | 2013-09-24 | Formulation aqueuse sterile injectable a base d'acide hyaluronique reticule et d'hydroxyapatite pour usage esthetique |
ZA2015/01697A ZA201501697B (en) | 2012-10-08 | 2015-03-12 | Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
IL237848A IL237848B (en) | 2012-10-08 | 2015-03-19 | Sterile aqueous injectable formulation based on cross-linked lauronic acid and hydroxyapatite for esthetic use |
IN2298DEN2015 IN2015DN02298A (fr) | 2012-10-08 | 2015-03-20 | |
HK15111274.7A HK1210429A1 (en) | 2012-10-08 | 2015-11-16 | Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
US15/356,885 US10463762B2 (en) | 2012-10-08 | 2016-11-21 | Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
US15/913,086 US10493006B2 (en) | 2012-10-08 | 2018-03-06 | Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
US15/941,735 US10434040B2 (en) | 2012-10-08 | 2018-03-30 | Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1259577 | 2012-10-08 | ||
FR1259577 | 2012-10-08 |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/433,927 A-371-Of-International US20150257989A1 (en) | 2012-10-08 | 2013-09-24 | Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
US15/356,885 Continuation US10463762B2 (en) | 2012-10-08 | 2016-11-21 | Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
US15/356,885 Continuation-In-Part US10463762B2 (en) | 2012-10-08 | 2016-11-21 | Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
US15/913,086 Continuation US10493006B2 (en) | 2012-10-08 | 2018-03-06 | Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014056722A2 WO2014056722A2 (fr) | 2014-04-17 |
WO2014056722A3 true WO2014056722A3 (fr) | 2014-07-10 |
Family
ID=47295066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2013/069874 WO2014056722A2 (fr) | 2012-10-08 | 2013-09-24 | Formulation aqueuse stérile injectable à base d'acide hyaluronique réticulé et d'hydroxyapatite pour usage esthétique |
Country Status (22)
Country | Link |
---|---|
US (2) | US20150257989A1 (fr) |
EP (1) | EP2903589B1 (fr) |
JP (1) | JP6342906B2 (fr) |
KR (1) | KR101773989B1 (fr) |
CN (1) | CN104703582B (fr) |
AR (1) | AR092933A1 (fr) |
AU (1) | AU2013329751B2 (fr) |
BR (1) | BR112015007772B1 (fr) |
CA (1) | CA2887316C (fr) |
ES (1) | ES2668689T3 (fr) |
HK (1) | HK1210429A1 (fr) |
IL (1) | IL237848B (fr) |
IN (1) | IN2015DN02298A (fr) |
LT (1) | LT2903589T (fr) |
MX (1) | MX360833B (fr) |
PL (1) | PL2903589T3 (fr) |
RU (1) | RU2648450C2 (fr) |
SG (1) | SG11201502743PA (fr) |
TR (1) | TR201807119T4 (fr) |
TW (1) | TWI641393B (fr) |
WO (1) | WO2014056722A2 (fr) |
ZA (1) | ZA201501697B (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2885884A1 (fr) * | 2012-10-08 | 2014-04-17 | Aptissen S.A. | Formulation aqueuse sterile injectable a base d'acide hyaluronique reticule et d'hydroxyapatite pour usage therapeutique |
US10463762B2 (en) * | 2012-10-08 | 2019-11-05 | Anteis S.A. | Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
TWI716365B (zh) * | 2014-11-13 | 2021-01-21 | 德商梅茲製藥有限兩合公司 | 注射型真皮填充劑組合物及其套組、製備方法、與使用 |
US10004824B2 (en) | 2015-05-11 | 2018-06-26 | Laboratoires Vivacy | Compositions comprising at least one polyol and at least one anesthetic |
FR3036035B1 (fr) * | 2015-05-11 | 2018-10-05 | Laboratoires Vivacy | Compositions comprenant au moins un polyol et au moins un anesthesique |
JP6660469B2 (ja) | 2015-11-24 | 2020-03-11 | ビーエムアイ コリア カンパニー リミテッド | ヒアルロン酸誘導体およびdna分画物が含まれているヒアルロン酸注射用組成物およびその利用 |
FR3044557B1 (fr) * | 2015-12-07 | 2017-12-01 | Benedicte Vincente Gavard Molliard Tauzin | Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition |
KR101886413B1 (ko) * | 2016-03-16 | 2018-08-10 | 주식회사 엘앤씨바이오 | 히알루론산에 기반한 연조직 충진 조성물의 제조 방법 |
PL3377126T3 (pl) | 2016-07-27 | 2019-08-30 | Marbelle Threads Ltd. | Nici usieciowanego kwasu hialuronowego i hydroksyapatytu |
CA3035153A1 (fr) * | 2016-09-07 | 2018-03-15 | Luminera Derm Ltd. | Gels injectables comprenant de l'acide hyaluronique reticule et de l'hydroxyapatite, et leurs procedes de fabrication |
IT201700008651A1 (it) * | 2017-01-26 | 2018-07-26 | Beauty System Pharma Ltd | Acido ialuronico reticolato con agenti reticolanti di tipo naturale o semisintetico |
CN107496990A (zh) * | 2017-08-15 | 2017-12-22 | 广东泰宝医疗器械技术研究院有限公司 | 一种可注射的抗菌软骨修复水凝胶及其制备方法 |
WO2019073386A1 (fr) * | 2017-10-10 | 2019-04-18 | E.N.A. Impeccable Skincare Solutions Ltd | Procédé de fabrication et compositions de comblement dermique contenant de l'acide hyaluronique et de l'hydroxyapatite |
WO2019182745A1 (fr) | 2018-03-19 | 2019-09-26 | Bryn Pharma, LLC | Formulations pour la pulvérisation d'épinéphrine |
WO2019197608A1 (fr) | 2018-04-13 | 2019-10-17 | Merz Pharma Gmbh & Co. Kgaa | Charge dermique à base d'acide hyaluronique réticulé, de particules de matière de phosphate de calcium et de carboxyméthylcellulose, son procédé de préparation et ses utilisations |
CN108744054A (zh) * | 2018-06-15 | 2018-11-06 | 北京水元生生物科技有限公司 | 一种注射型美容整形用面部填充剂组合物凝胶及其制备方法 |
WO2020095079A1 (fr) * | 2018-11-06 | 2020-05-14 | Kylane Laboratoires Sa | Composition injectable contenant de l'acide hyaluronique pour des applications au niveau du corps |
CN111166686A (zh) * | 2018-11-12 | 2020-05-19 | 无锡市伙伴日化科技有限公司 | 一种玻尿酸爽肤水 |
US20230108822A1 (en) * | 2020-02-06 | 2023-04-06 | Merz Pharma Gmbh & Co. Kgaa | Injectable composition for skin and soft tissue augmentation |
ES2947097A1 (es) * | 2022-02-01 | 2023-08-01 | Martinez Miguel Angel Gomariz | Metodo cosmetico de rejuvenecimiento de la piel |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004011053A1 (fr) * | 2002-07-31 | 2004-02-05 | Dentsply International Inc. | Mastic de reparation osseuse comprenant une substance particulaire poreuse et un gel support |
FR2938187A1 (fr) * | 2008-11-07 | 2010-05-14 | Anteis Sa | Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur |
FR2945949A1 (fr) * | 2009-05-26 | 2010-12-03 | Anteis Sa | Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6537574B1 (en) * | 1992-02-11 | 2003-03-25 | Bioform, Inc. | Soft tissue augmentation material |
DE69331096T2 (de) | 1992-02-28 | 2002-08-14 | Cohesion Tech Inc | Injektierbare, keramische verbindungen sowie verfahren zur deren herstellung und anwendung |
FR2850282B1 (fr) | 2003-01-27 | 2007-04-06 | Jerome Asius | Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation |
US20100004700A1 (en) | 2008-03-05 | 2010-01-07 | Neville Alleyne | Method of treating tissue with a suspenson of tricalcium hydroxyapatite microspheres |
CN101596328A (zh) | 2008-06-02 | 2009-12-09 | 山东省生物药物研究院 | 一种复合生物材料及其制备方法和应用 |
NZ599527A (en) | 2009-11-09 | 2014-04-30 | Spotlight Technology Partners Llc | Fragmented hydrogels |
US8915043B2 (en) * | 2011-05-25 | 2014-12-23 | General Electric Company | Bolt connection for a wind tower lattice structure |
ITAN20110138A1 (it) * | 2011-10-12 | 2012-01-11 | Regenyal Lab S R L | Sintesi di un gel iniettabile multifasico a base di acido ialuronico monofasico libero e reticolato e di acido ialuronico bifasico associato con idrossiapatite con inibitore della ialuronidasi microincapsulato. |
CA2885884A1 (fr) | 2012-10-08 | 2014-04-17 | Aptissen S.A. | Formulation aqueuse sterile injectable a base d'acide hyaluronique reticule et d'hydroxyapatite pour usage therapeutique |
-
2013
- 2013-09-24 LT LTEP13766322.5T patent/LT2903589T/lt unknown
- 2013-09-24 KR KR1020157009968A patent/KR101773989B1/ko active IP Right Grant
- 2013-09-24 SG SG11201502743PA patent/SG11201502743PA/en unknown
- 2013-09-24 MX MX2015004307A patent/MX360833B/es active IP Right Grant
- 2013-09-24 JP JP2015536048A patent/JP6342906B2/ja active Active
- 2013-09-24 BR BR112015007772A patent/BR112015007772B1/pt active IP Right Grant
- 2013-09-24 CN CN201380052596.3A patent/CN104703582B/zh active Active
- 2013-09-24 ES ES13766322.5T patent/ES2668689T3/es active Active
- 2013-09-24 TR TR2018/07119T patent/TR201807119T4/tr unknown
- 2013-09-24 AU AU2013329751A patent/AU2013329751B2/en active Active
- 2013-09-24 PL PL13766322T patent/PL2903589T3/pl unknown
- 2013-09-24 EP EP13766322.5A patent/EP2903589B1/fr active Active
- 2013-09-24 CA CA2887316A patent/CA2887316C/fr active Active
- 2013-09-24 US US14/433,927 patent/US20150257989A1/en not_active Abandoned
- 2013-09-24 WO PCT/EP2013/069874 patent/WO2014056722A2/fr active Application Filing
- 2013-09-24 RU RU2015115974A patent/RU2648450C2/ru active
- 2013-10-08 AR ARP130103635A patent/AR092933A1/es active IP Right Grant
- 2013-10-08 TW TW102136381A patent/TWI641393B/zh active
-
2015
- 2015-03-12 ZA ZA2015/01697A patent/ZA201501697B/en unknown
- 2015-03-19 IL IL237848A patent/IL237848B/en active IP Right Grant
- 2015-03-20 IN IN2298DEN2015 patent/IN2015DN02298A/en unknown
- 2015-11-16 HK HK15111274.7A patent/HK1210429A1/xx unknown
-
2018
- 2018-03-06 US US15/913,086 patent/US10493006B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004011053A1 (fr) * | 2002-07-31 | 2004-02-05 | Dentsply International Inc. | Mastic de reparation osseuse comprenant une substance particulaire poreuse et un gel support |
FR2938187A1 (fr) * | 2008-11-07 | 2010-05-14 | Anteis Sa | Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur |
FR2945949A1 (fr) * | 2009-05-26 | 2010-12-03 | Anteis Sa | Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme. |
Non-Patent Citations (2)
Title |
---|
"Hyaluronan Derivatives and Injectable Gels for Tissue Engineering", vol. 573, 14 November 2008, UNIVERSITETBIBLIOTEKET, Uppsala, Sweden, ISBN: 978-9-15-547335-8, article KRISTOFFER BERGMAN: "Hyaluronan Derivatives and Injectable Gels for Tissue Engineering", XP055070428 * |
BAKOS D ET AL: "Hydroxyapatite-collagen-hyaluronic acid composite", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 20, no. 2, 1 January 1999 (1999-01-01), pages 191 - 195, XP004168893, ISSN: 0142-9612, DOI: 10.1016/S0142-9612(98)00163-X * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014056722A3 (fr) | Formulation aqueuse stérile injectable à base d'acide hyaluronique réticulé et d'hydroxyapatite pour usage esthétique | |
MX2015004165A (es) | Formulacion acuosa esteril inyectable a base de acido hialuronico reticulado y de hidroxiapatita para uso terapeutico. | |
WO2013106385A3 (fr) | Système et procédés de détermination de l'élasticité d'un tissu | |
EP2977066A3 (fr) | Composition hémostatique sèche | |
MX2017006232A (es) | Relleno dermico a base de acido hialuronico reticulado y lubricante de carboximetilcelulosa. | |
WO2014093489A3 (fr) | Membrane à hydrogel pour la prévention de l'adhérence | |
GEP201706780B (en) | Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c | |
WO2016178586A3 (fr) | Compositions de collagène, leur préparation et leurs utilisations | |
UA114531C2 (uk) | Противірусні сполуки проти rsv | |
EP2243510A3 (fr) | Modulation haute fréquence sélective de la moelle épinière pour inhiber la douleur avec des effets secondaires réduits, systèmes et procédés associés | |
EP3216462A3 (fr) | Compositions contenant un anticorps stable | |
EP3682875A3 (fr) | Méthodes de traitement du syndrome métabolique pédiatrique | |
WO2008147817A3 (fr) | Particules d'acide hyaluronique revêtues | |
WO2012129161A3 (fr) | Solutions stabilisées d'acide hypohalogéneux | |
WO2011159840A3 (fr) | Phénylthioacétates, compositions et procédés d'application | |
EP3892285A3 (fr) | Matériau de silicium poreux pour une utilisation en tant qu'ingrédient actif pharmaceutiques ou alimentaire | |
MX2013008433A (es) | Dispositivo medico que contiene una composicion en torta que comprende aripiprazol como ingrediente activo, y una composicion en torta que comprende aripirazol como ingrediente activo. | |
WO2008063503A3 (fr) | Méthodes d'obtention de chitosan à très faible concentration en endotoxine produit ainsi obtenu et méthode de détermination précise de la réponse cellulaire inflammatoire et and anti-inflammatoire à ce produit | |
EP4233896A3 (fr) | Procédé de préparation d'un lysat immunogène, lysat obtenu, cellules dendritiques chargées d'un tel lysat et composition pharmaceutique comprenant le lysat ou les cellules dendritiques | |
WO2015017340A3 (fr) | Adhésif pour tissu à faible gonflement et formulations d'obturant | |
WO2010007441A3 (fr) | Phosphopeptides et leur utilisation | |
MX2013013828A (es) | Una composicion para la preparacion de acido hialuronico reticulado viscoelastico, y acido hialuronico reticulado obtenido al usar la misma. | |
WO2011107866A3 (fr) | Dérivés silyliques de polysaccharides | |
WO2011163512A3 (fr) | Traitement anticancéreux | |
WO2019099860A3 (fr) | Traitement de plaie contenant du collagène et un agent de réduction de gélatine, et méthode d'aide à la cicatrisation de plaie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13766322 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 237848 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2887316 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2015/004307 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14433927 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2015536048 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2013329751 Country of ref document: AU Date of ref document: 20130924 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20157009968 Country of ref document: KR Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112015007772 Country of ref document: BR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013766322 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2015115974 Country of ref document: RU Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 112015007772 Country of ref document: BR Kind code of ref document: A2 Effective date: 20150407 |